Figure 2. Mefloquine treatment decreases cochlear outer and inner hair cell survival, while NAD⁺ treatment protects the hair cells.

Averaged cochleogram from untreated (a), 5 mM NAD⁺ treatment (b), 20 mM NAD⁺ treatment (c), 35 µM mefloquine treatment (d), 50 µM mefloquine treatment (e), 35 µM mefloquine + 5 mM NAD⁺ treatment (f), 35 µM mefloquine + 20 mM NAD⁺ (g), 50 µM mefloquine + 5 mM NAD⁺ (h) or 50 µM mefloquine + 20 mM NAD⁺ (i).